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The immediate early gene activity-regulated cytoskeletal protein (Arc)/
Arg3.1 and the neurotrophin brain-derived neurotrophic factor (BDNF) play
important roles in synaptic plasticity and learning and memory in the mam-
malian brain. However, the mechanisms by which BDNF regulates the
expression of Arc/Arg3.1 are unclear. In this study, we show that BDNF acts
via the ERK1/2 pathway to activate the nuclear kinase mitogen- and stress-
activated protein kinase 1 (MSK1). MSK1 then induces Arc/Arg3.1 expres-
sion via the phosphorylation of histone H3 at the Arc/Arg3.1 promoter.
MSK1 can also phosphorylate the transcription factor cyclic-AMP response
element-binding protein (CREB) on Ser133. However, this is not required
for BDNF-induced Arc.Arg3.1 transcription as a Ser133Ala knockin muta-
tion had no effect on Arc/Arg3.1 induction. In parallel, ERK1/2 directly acti-
vates Arc/Arg3.1 mRNA transcription via at least one serum response
element on the promoter, which bind a complex of the Serum Response
Factor (SRF) and a Ternary Complex Factor (TCF).
The transcriptional regulation of immediate early (IE)
genes plays an important role in translating incoming
signals into an appropriate cellular response. IE genes
have been implicated in many neuronal processes rang-
ing from development and synapse formation to
synaptic plasticity and the encoding of memory [1–3].
Multiple pathways have been implicated in the regula-
tion of IE genes in neurons, however one pathway that
has received significant attention is the classical
MAPK pathway, which leads to the activation of
ERK1 and 2 [4]. The ERK1/2 cascade can promote IE
gene transcription via several mechanisms, including
its ability to activate transcription from serum
response elements (SREs) and cyclic-AMP response
elements (CREs) that are found in the promoters of
many IE genes [2,5].
Serum response elements can be bound by a combina-
tion of the serum response factor and an ETS domain tran-
scription factor such as Elk1. ERK1 and 2 are able to
directly phosphorylate Elk1, leading to transcriptional acti-
vation of SRE containing promoters [6]. CREs are bound
by cyclic-AMP response element-binding protein (CREB),
or the related transcription factors ATF1 or CREM. Like
Elk1, the transcriptional activity of CREB can be regulated
by phosphorylation [7,8]. CREB was initially identified as
a substrate of PKA downstream of cAMP signalling [7,8].
PKA-mediated phosphorylation of CREB on Ser133 pro-
motes CREB-dependent transcription via the recruitment
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of the coactivator proteins CBP and p300 [7]. Subse-
quently, other kinases have been found to induce CREB
Ser133 phosphorylation including mitogen- and stress-acti-
vated protein kinase 1 (MSK1) and 2 downstream of the
ERK1/2 and p38 MAPK pathways [9]. The role of MSK-
mediated CREB phosphorylation was initially unclear, as
it is unable to promote CBP or p300 recruitment [10].
Analysis of CREB Ser133Ala knockin (KI) mice has how-
ever demonstrated that MAPK-induced Ser133 phospho-
rylation of CREB is essential for the efficient induction of
CREB-dependent IE genes in fibroblasts and macrophages
[11,12].
Mitogen- and stress-activated protein kinase localise
to the nucleus and, in addition to CREB, they have been
found to phosphorylate other nuclear proteins including
the histone H3, HMG14 and Trim28 [13–15]. In line
with this, a major function of MSKs is the regulation of
a subset of IE genes, which has led to the discovery of
roles for MSKs in the regulation of innate immunity
[11,16] and, as discussed below, neuronal function.
In most cell types, MSK1 and MSK2 are able to
compensate for each other, and knockout of both
MSK1 and MSK2 together is required to block the
phosphorylation of MSK substrates [9,17]. In contrast,
in primary cortical neuronal cultures, knockout of
MSK1 alone is sufficient to prevent CREB phosphory-
lation in response to neurotrophins such as brain-
derived neurotrophic factor (BDNF), an effect that
may be due to the low expression of MSK2 in neu-
ronal cells [18]. This importance for MSK1 in neurons
is reflected in the finding that knockout of MSK1 in
mice can result in behavioural deficits in a variety of
models of learning and memory.
Mitogen- and stress-activated protein kinase 1 is acti-
vated in hippocampal CA1 pyramidal neurons during
fear conditioning [19] and MSK1 knockout mice have a
mild memory formation deficit in Pavlovian fear condi-
tioning and spatial learning models [20]. In these experi-
ments, MSK1 was suggested to be the major kinase
responsible for both the CREB and histone H3 phos-
phorylation induced by these models [19,20]. In agree-
ment with this, MSK1/2 double knockout mice showed
a deficit in learning and histone phosphorylation in a
forced swimming test, another paradigm of hippocam-
pal memory [21]. The role of MSK1 is not restricted to
the hippocampus. Cocaine administration activates
MSK1 in the striatum of mice, and MSK1 knockouts
show decreased locomotor sensitisation in response to
repeated cocaine administration [22–24]. In addition,
MSK1 has recently been implicated in the development
of pain after injury [25,26].
The mechanism underlying how MSKs affect CNS
function is not fully understood. Loss of MSK1
protein or kinase activity does not appear to have any
gross effects on CNS development [22,27]. MSK1/2
double knockout does however result in decreased
spine density in the hippocampus and a lower prolifer-
ative rate in progenitor cells in the subgranular zone
[28]. These defects were especially apparent in mice
that had been subject to a period of environmental
enrichment (EE) [28] and may contribute to the lack
of effect of enrichment on cognitive function in MSK1
knockout mice [29].
In agreement with this, enrichment enhanced the
amplitude of miniature excitatory postsynaptic cur-
rents in wild-type mice, but not mice with a D194A
kinase dead KI mutation in the N-terminal kinase
domain of MSK1, which also showed a blunted
increase in spine density following EE [27]. MSK1
D194A KI mice raised under standard housing condi-
tions, showed an impairment in basal synaptic trans-
mission, but not long-term potentiation, nor indeed
several forms of spatial reference memory in the water
maze [30]. These observations suggest that the kinase
activity of MSK1 may be required for longer term,
homeostatic responses to changes in synaptic activity.
This is consistent with the observation that MSK1
D194A KI hippocampal neurons fail to undergo
homeostatic scaling in response to chronic (24 h)
synaptic activity deprivation caused by blocking action
potentials with the voltage-gated sodium channel
blocker TTX [27]. Homeostatic scaling is a process
that allows global regulation of synaptic strength
within a neuron, and has previously been linked to
both BDNF signalling [31] and the activity-regulated
cytoskeletal protein (Arc/Arg3.1), an IE gene widely
implicated in a range of synaptic and experience-
dependent plasticity [32–35]. In wild-type neurons,
TTX treatment downregulated Arc/Arg3.1 protein
levels, but this did not occur in MSK1 D194A KI neu-
rons [27]. How MSK1 regulates Arc/Arg3.1 was not
however established in this study.
Here, we report that in primary cortical neuronal
cultures, Arc/Arg3.1 transcription is directly regulated
by MSK1 in response to BDNF, and that this occurs
independently of CREB phosphorylation but corre-
lates with the phosphorylation of histone H3 on the
Arc/Arg3.1 promoter.
Methods
Mice
The generation and genotyping MSK1/2 double
knockout, MSK1 D194A KI and CREB S133A KI
mice has been described previously [17,27,36]. MSK1
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D194A KI mice were generated and maintained on a
C57/Bl6 background. MSK1 and MSK2 knockout
mice were backcrossed onto C57/Bl6 for 12 genera-
tions and the CREB S133A mice backcrossed to C57/
Bl6 for six generations. As described in [36], the
S133A mutation was induced in the endogenous
CREB gene specifically in neurons using Nestin-Cre;
for these cultures CREB wild-type Nestin-Cre+ve cells
were used as controls. All mice were maintained under
specific pathogen-free conditions in individually venti-
lated cages and allowed free access to food and water.
Work was carried out under a UK Home Office
license and approved by the University of Dundee and
University of Warwick Welfare and Ethical Use of
Animals Committee.
Cortical neuronal culture
The neocortex was excised from postnatal pups (day 0
or 1), finely minced and digested 37 °C for 10 min
with trypsin (0.05%, Invitrogen, Paisley, UK) in disso-
ciation media (90 mM Na2SO4, 30 mM K2SO4, 16 mM
MgCl2, 0.25 mM CaCl2, 32 mM HEPES). The tissue
was rinsed by gravity precipitation twice in dissocia-
tion media and twice in Neurobasal A (Invitrogen)
and gently triturated into a single-cell suspension with
a 5 mL plastic serological pipette. The supernatant
containing single cells was spun down and the cells
were resuspended in Neurobasal A (Invitrogen) supple-
mented with 2% B27, 1 mM L-glutamine, 50 UmL1
penicillin, and 50 lgmL1 streptomycin (Invitrogen)
and plated on poly-D-lysine-coated 6 or 12 well plates
(100 lgmL1; Sigma, Poole, UK). Cells were used
between 7 and 10 days in culture at which point the
density was 80–90% confluent.
Stimulation of cortical neurons involved application
of BDNF (2, 10 and 50 ngmL1; Cambridge Bio-
science, UK) and N-Methyl-D-aspartic acid (NMDA;
20 lM; Sigma-Aldrich). Enzyme and transcription inhi-
bitors used in the study are as follows: the PI3 kinase
inhibitor PI103 (10 lM; Merck, Watford, UK); the p38
inhibitor SB203580 (5 lM; Merck); the CaMK inhibi-
tor Kn-93 (10 lM; Merck); the MEK1/2 inhibitor
PD184352 (2 lM; Axon Medchem, Groningen, Nether-
lands), the MSK1 inhibitor SB-747651A (10 lM; Axon
Medchem), the broad spectrum kinase inhibitor H89
(25 lM; Merck), and the inhibitor of transcription,
actinomycin D (1 lgmL1; Sigma-Aldrich).
Immunoblotting
Cells were lysed directly into SDS sample buffer. Sam-
ples were run on 12% polyacrylamide gels and
transferred onto nitrocellulose using standard tech-
niques. Primary antibodies against ERK1/2, phospho
ERK1/2, CREB and phospho-Ser133 CREB were
from Cell Signalling. The antibody against phospho-
Ser10 histone H3 was from Millipore. Detection was
with HRP-conjugated secondary antibodies (Pierce)
using Supersignal ECL reagent (Pierce, Fisher Scienti-
fic - UK Ltd, Loughborough, UK).
qPCR
Following stimulation, total RNA was isolated using
RNeasy kits (Qiagen, Manchester, UK) according to
the manufacturer’s protocols. RNA was reverse-tran-
scribed using iScript (Qiagen) and qPCR carried out
using Sybergreen-based detection (Bio-Rad, Watford,
UK or Takara, Saint-Germain-en-Laye, France). The
primers used are listed in Table 1. Fold-stimulation
was calculated relative to unstimulated wild-type
samples using 18s levels as a loading control [37].
ChIP
Primary cortical neurons were either left unstimulated
or stimulated with BDNF (50 ngmL1) for 30 min.
Cells were then fixed for 10 minutes with 1% formalde-
hyde and chromatin was isolated using the chromatin
immunoprecipitation (ChIP)-IT Express magnetic kit
(Active Motif, Carlsbad, CA, USA) according to the
manufacturer’s protocols. ChIP was performed using
6 lg phospho-S10 Histone H3 antibody per IP. Primers
sequences are provided in Table 1.
Luciferase assays
To generate Arc/Arg3.1 reporter constructs, 1302 to
+98 (sequence starting AGTGGGGGGCAT to CCT
CCGGCACCG) of the Arc/Arg3.1 promoter was
Table 1. qPCR primer sequences.
Use Primer Sequence
qPCR Arc/Arg3.1 sense CGAGCCCTGGTGTGGATAC
qPCR Arc/Arg3.1 antisense ACCGAGCCCTGCTTGAAC
qPCR Nur77 sense CCTGTTGCTAGAGTCTGCCTTC
qPCR Nur77 antisense CAATCCAATCACCAAAGCCACG
qPCR 18s sense GTAACCCGTTGAACCCCATT
qPCR 18s antisense CCATCCAATCGGTAGTAGCG
ChIP P1 TGGTGTAAGTCAAGAAGG
ChIP P2 AAGATGCCATATAAGGAATG
ChIP P3 GTAATAACCTGCCTTAGCC
ChIP P4 GTGACTAATGTGCTCTGC
ChIP P5 CGAGCCCTGGTGTGGATAC
ChIP P6 ACCGAGCCCTGCTTGAAC
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PCR amplified and cloned into the pGL4 luciferase
vector (Promega, Southampton, UK). PCR-based
mutagenesis was used to mutate the SRE (CCTTA
TATGG to TTTTATATTT) and EGR-binding site
(CGGGCG to TTTTTT). All inserts were fully
sequenced to ensure the absence of random PCR-gen-
erated mutations. Cortical neurons were transfected at
3 DIV using Lipofectamine 2000 (Invitrogen) and
analysed on day 5. A Renillia luciferase vector (pRL-
CMV, Promega) was used as a transfection control.
Luciferase activity was detected in cell lysates using
the dual luciferase assay system (Promega) according
to the manufacturer’s instructions.
Statistical analysis
Data are presented as mean  1 SD of multiple biologi-
cal replicates. Statistical analysis of the data involved
one- or two-way ANOVAs as appropriate as described in
the figure legends. Statistical significance was accepted if
P < 0.05. ORIGINPRO 2016 (OriginLab, Northampton,
UK) was used for statistical analysis.
Results
MSK1 promotes Arc/Arg3.1 transcription
downstream of BDNF
In cultures of primary cortical neurons, Arc/Arg3.1
mRNA levels were increased by stimulation with BDNF
(Fig. 1). BDNF is known to activate a range of intracel-
lular signalling pathways including PI3 kinase, Ca2+
and MAPK signalling pathways [38,39]. As kinase inhi-
bitors are available that target these pathways [40], a
range of compounds to inhibit the different BDNF-
activated signalling pathways was used. The induction
of Arc/Arg3.1 mRNA following BDNF stimulation was
not blocked by the PI3 kinase inhibitor PI103, the p38
inhibitor SB203580 or the CaMK inhibitor Kn-93
(Fig. 1A) at concentrations previously established to
inhibit the relevant kinases in cells [41]. The induction of
Arc/Arg3.1 mRNA was however completely abolished
by PD184352 (Fig. 1A), a MEK1/2 inhibitor that
blocks the activation of ERK1/2 [41].
Although MSK1 can be activated by either the
ERK1/2 or p38a MAPK pathways [42], we have previ-
ously shown in BDNF-stimulated cortical neuronal
cultures that the ERK1/2, but not the p38 pathway, is
responsible for MSK1 activation [18]. The requirement
for ERK1/2 activation in Arc/Arg3.1 mRNA induc-
tion could therefore be consistent with a role for
MSK1. Following stimulation with BDNF, in wild-
type cells the induction of Arc/Arg3.1 mRNA was
maximal at 1 h, although strong induction was still
seen at 3 h (Fig. 1B). Double knockout of MSK1 and
2 (MSK1/2 KO) greatly reduced the initial induction
of Arc/Arg3.1 mRNA by BDNF at 1 h, although the
knockout had less effect at 3, 6 and 8 h, where the
induction of Arc/Arg3.1 was no different between
wild-type and MSK1/2 KO mice (Fig. 1B). In cortical
neurons, MSK1 is expressed at much higher levels
than MSK2 and knockout of MSK1 alone is sufficient
to block BDNF-induced CREB phosphorylation [18].
To examine the importance of MSK1 kinase activity
in the BDNF-induced induction of Arc/Arg3.1
mRNA, we utilised an MSK1 KI mouse with a
D194A mutation that destroys the catalytic activity of
the N-terminal domain [27]. Although MSKs are unu-
sual in containing two kinase domains, the only
known role of the C-terminal kinase domain is in the
activation of the N-terminal domain. Inactivation of
the N-terminal domain has previously been shown to
block the phosphorylation of MSK substrates [43,44].
Analysis of Arc/Arg3.1 mRNA induction in neuronal
cultures from MSK1 D194A KI mice gave similar
results to MSK1/2 KO, with a significant attenuation
of Arc/Arg3.1 mRNA induction by BDNF at 1 h
(Fig. 1B). This difference between wild-type and
MSK1 D194A KI cells was also apparent when lower
concentrations of BDNF (2 and 10 ngmL1) were
used for stimulation (Fig. 1C). The absence of kinase
activity in the MSK1 D194A mutant was confirmed
by the reduction of CREB S133 and histone H3 S10
phosphorylation in response to BDNF in cortical neu-
ronal cultures from the MSK1 D194A mice (Fig. 1D).
To confirm the genetic results of MSK inhibition, we
utilised a recently described MSK1 inhibitor, SB-
747651A [45]. Pharmacological inhibition of MSK1 by
SB-747651A was able to reduce the induction of Arc/
Arg3.1 mRNA by BDNF (Fig. 1E). Similar results
were obtained with H89 (Fig. 1E), a compound that
can target several kinases including MSK1 [45].
MSK1 regulates Arc/Arg3.1 transcription
independently of CREB
Changes in mRNA levels can reflect a change in either
transcription or in mRNA stability. To address by which
mechanism MSK1 might regulate Arc/Arg3.1 mRNA,
the primary transcript for Arc/Arg3.1 was analysed and
actinomycin D chase experiments carried out. Changes in
the level of primary unspliced transcripts can give a better
indication of changes in transcription compared to mea-
surement of the spliced mRNA. In wild-type cells, BDNF
was able to increase the levels of the Arc/Arg3.1 primary
transcript. This induction was significantly lower in
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Fig. 1. MSK1 promotes Arc/Arg3.1 mRNA induction downstream of BDNF. (A) Wild-type cortical neuronal cultures were pretreated as
indicated for 1 h with 2 lM PD184352, 5 lM SB203580, 10 lM Kn-93 or 10 lM PI103. Cells were stimulated with 50 ngmL1 BDNF for 1 h,
lysed and total RNA extracted. Induction of Arc/Arg3.1 mRNA was then determined by qPCR using 18s as a reference gene. Error bars
represent the standard deviation of six stimulations except for PI103 where n = 3. A one-way ANOVA showed a significant difference
across the treatment groups (F4,21 = 14.802; P < 0.0001) with a selective inhibitory effect on BDNF-induced Arc/Arg3.1 mRNA induction by
PD184352, as assessed by a post hoc Bonferroni test (P < 0.0001, indicated by ***). (B) Cortical neuronal cultures were established from
wild-type, MSK1/2 double knockout (KO) or MSK1 D194A KI mice. Cells were stimulated with 50 ngmL1 BDNF for the indicated times
and Arc/Arg3.1 mRNA induction determined by qPCR. Error bars represent the standard deviation of multiple experiments with 8–19
independent stimulations per condition. A two-way ANOVA revealed a significant effect of genotype (F2,148 = 24.259; P < 0.0001) and
duration of BDNF exposure (F4,148 = 32.446; P = 0), and a significant interaction between genotype and BDNF exposure (F8,148 = 14.559;
P < 0.001) on Arc/Arg3.1 mRNA induction. Post hoc Bonferroni comparison showed a significant difference (P < 0.0001, indicated by ***) at
1 h between wild-type and MSK1/2 KO, and wild-type and MSK1 D194A KI, but no difference (P = 1) between MSK1/2 KO and MSK1 KI.
There was no difference in Arc/Arg3.1 induction between genotypes at 3, 6 and 8 h. (C) Wild-type or MSK1 D194A KI cortical neurons were
stimulated with the indicated concentrations of BDNF for 60 min. The induction of Arc/Arg3.1 mRNA was then determined by qPCR. Error
bars represent the standard deviation of eight stimulations per condition. A two-way ANOVA showed a significant main effect of BDNF
concentration (0–50 ngmL1) on Arc/Arg3.1 mRNA induction in wild-type and MSK1 KI neurons (F3,56 = 31.136, P < 0.0001). Importantly,
this induction also showed a main effect of genotype (F1,56 = 67.269, P < 0.0001) and an interaction between genotype and BDNF
concentration (F3,56 = 12.697, P < 0.0001), indicative of a major role for MSK1 in the BDNF-dependent induction of Arc/Arg3.1. A P value of
< 0.0001 is indicated by ***. (D) Wild-type or MSK1 D194A KI cortical neurons were stimulated with 50 ngmL1 BDNF for the indicated
times and the levels of total and phospho ERK1/2, Ser10 phosphorylated histone H3 and total and Ser133 phosphorylated CREB determined
by immunoblotting. (E) Wild-type cortical neurons were pretreated as indicated for 1 h with either 10 lM SB-747651A or 25 lM H89. Cells
were then stimulated for 1 h with 50 ngmL1 BDNF and the induction of Arc/Arg3.1 mRNA determined by qPCR.
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MSK1 D194A KI cells (Fig. 2A). While this would sug-
gest that MSK1 can regulate Arc/Arg3.1 transcription, it
does not in itself exclude that MSK may also regulate
Arc/Arg3.1 mRNA stability. To address this, actino-
mycin D was used to block transcription and the remain-
ing Arc/Arg3.1 mRNA levels determined. In both
wild-type and MSK1 D194A KI cells, Arc/Arg3.1 was
lost at a similar rate following actinomycin D addition
(Fig. 2B). Analysis of the level of the primary unspliced
Arc/Arg3.1 transcript in the actinomycin D chase experi-
ment showed that it was greatly decreased with 30 min of
actinomycin D addition (Fig. 2C), consistent with the
rate of splicing being faster than the rate of degradation
of the Arc/Arg3.1 mRNA. Together, the above results
suggest that MSK1 regulates Arc/Arg3.1 mRNA induc-
tion primarily at the level of transcription.
To identify how MSK might regulate the Arc/
Arg3.1 promoter, a 1.4 kb fragment corresponding to
1302 to +98 of the Arc/Arg3.1 genomic sequence was
fused to a luciferase reporter and transfected into pri-
mary cortical neuronal cultures. This construct was
inducible by BDNF, as evidenced by an increased luci-
ferase activity following a 4 h treatment with BDNF
(Fig. 2D). The induction of this reporter was reduced
by either the ERK1/2 pathway inhibitor PD184352 or
the MSK inhibitor SB-747651A (Fig. 2D). The ability
of BDNF to induce the luciferase reporter in MSK1
D194A KI cortical neuronal cultures was also lower
than in wild-type cells (Fig. 2E).
To date, most of the target genes identified for MSKs
are also regulated by the MSK substrate CREB [12].
The majority of active CRE sites are thought to be
located within 1 kb proximal to the transcriptional start
site [46]. In silico analysis of the sequence cloned into
the Arc/Arg3.1 reporter did not reveal any strong con-
sensus CREB binding sites within this region, suggest-
ing that MSK1 may regulate Arc/Arg3.1 independently
of CREB. It is possible however that CREB may bind
outside the region used in the Arc/Arg3.1 reporter, and
that the phosphorylation of CREB at these sites may
contribute to the ability of MSKs to regulate Arc/
Arg3.1 mRNA induction. To address this, we analysed
the effect of a KI mutation of Ser133 to alanine in the
endogenous CREB gene (CREB Ser133Ala KI [36]). To
confirm that the mutation of CREB at this site could
affect BDNF-induced transcription, we examined the
induction of nur77, a known MSK and CREB target
gene [12,37]. As expected, the induction of nur77
mRNA in response to BDNF was reduced by either
MSK1/2 knockout or CREB Ser133Ala KI (Fig. 3A).
The induction of the endogenous Arc/Arg3.1 mRNA by
BDNF was however not reduced by the CREB Ser133-
Ala KI mutation (Fig. 3B).
MSKs phosphorylate histone H3 at the
Arc/Arg3.1 promoter
The above results indicate MSKs may regulate Arc/
Arg3.1 induction independently of their ability to phos-
phorylate CREB. As MSKs also phosphorylate histone
H3 on Ser10 [13], the phosphorylation of histone H3 on
the Arc/Arg3.1 promoter was examined by ChIP. As
indicated in Fig. 4A, 3 primer sets were used to examine
potential histone H3 phosphorylation at regions in both
the Arc/Arg3.1 promoter and 1st exon. In primary corti-
cal neurons, BDNF strongly induced H3 phosphoryla-
tion in only one of these regions (Fig. 4B, C). The
ability of BDNF to induce histone H3 Ser10 phosphory-
lation was significantly reduced in neurons isolated from
the MSK1 D194A KI mice (Fig. 4C).
Arc/Arg3.1 transcription is regulated by Srf sites
Both Srf and Egr transcription factors have been linked
to Arc/Arg3.1 transcription [47–49]. The regions anal-
ysed by ChIP are located next to a potential SRE and 50
to an Egr family transcription factor binding site
(Fig. 5A). To test if these sites were important for the
BDNF activity at the Arc/Arg3.1 promoter, the effects of
mutating these sites on the induction of the Arc/Arg3.1
promoter were examined. Loss of the Egr site did not
prevent induction of the luciferase gene. However, muta-
tion of the putative SRE site blocked both the basal and
BDNF-induced expression of the reporter (Fig. 5B).
SREs bind a combination of Srf and a ternary complex
factor such as Elk1. In response to mitogens and growth
factors, ERK1/2 are able to phosphorylate Elk1, and
thus help stimulate transcriptional activation from SREs
[6,50]. ERK1/2 activation may therefore regulate the
induction of Arc/Arg3.1 promoter both directly via
phosphorylation of Elk1 and indirectly via the activation
of MSK1. To test this, the effect of blocking ERK1/2
activation on the remaining Arc/Arg3.1 mRNA induc-
tion in response to BDNF in MSK1 D194A KI neurons
was examined. In line with an additionalMSK1-indepen-
dent role for ERK1/2, the remaining Arc/Arg3.1 mRNA
induction in the MSK1/2 knockout cortical neurons was
blocked by preincubation with the ERK1/2 pathway
inhibitor PD184352 (Fig. 5C).
MSK1 is not critical for the induction of
Arc/Arg3.1 mRNA by NMDA
In neurons, Arc/Arg3.1 mRNA has been shown to be
induced by other stimuli in addition to neurotrophins.
As MSK1 plays an important role in Arc/Arg3.1
induction downstream of BDNF, we also examined if
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Fig. 2. MSK1 regulates the induction of the Arc/Arg3.1 promoter. (A) Wild-type or MSK1 D194A KI cortical neurons were stimulated with
2–50 ngmL1 BDNF for 60 min or left unstimulated. Induction of the primary transcript for Arc/Arg3.1 was determined by qPCR. Error bars
represent the standard deviation of eight stimulations. A two-way ANOVA showed a significant effect of treatment (F3,56 = 23.718;
P < 0.0001) and genotype (F1,56 = 35.889; P < 0.0001), and a significant genotype 9 treatment interaction (F3,56 = 6.167; P = 0.0011). Post
hoc Bonferroni comparison showed a significant difference in BDNF-dependent Arc/Arg3.1 induction between wild-type and MSK1 D194A
KI neurons (P < 0.001) at 10 and 50 ngmL1 BDNF, with no difference in basal levels (P = 0.16) and with no significant stimulation by
BDNF in MSK1 D194A KI neurons compared to control levels in MSK1 D194A KI neurons at any concentration of BDNF used. (B) Wild-type
or MSK1 D194A KI cortical neurons were stimulated with 50 ngmL1 BDNF for 90 min; 1 lgmL1 actinomycin D was added and mRNA
isolated a 0, 30, 60, 120 and 180 min after addition. Arc/Arg3.1 mRNA levels were then determined by qPCR. Error bars represent the
standard deviation of eight stimulations. A two-way ANOVA showed no main effect of genotype on mRNA stability over the time period
0.5–3 h after BDNF induction (F1,55 = 0.504, P = 0.481), nor an interaction between genotype and time (F3,55 = 0.290, P = 0.832). (C) Wild-
type or MSK1 D194A KI cortical neurons were stimulated with 50 ngmL1 BDNF for 90 min; 1 lgmL1 actinomycin D was then added
and mRNA isolated a 0 and 30 min after addition. Arc/Arg3.1 primary transcript levels were then determined by qPCR. Error bars represent
the standard deviation of eight stimulations. (D) Wild-type cortical neuronal cultures were transfected with an Arc/Arg3.1 luciferase reporter
construct (corresponding to the promoter region 1302 to +98) as described in the Methods. Cells were pretreated as indicated for 1 h with
2 lM PD184352 or 10 lM SB-747651A. Cells were then stimulated with 50 ngmL1 BDNF for 4 h, lysed and luciferase activity measured.
Error bars represent that standard deviation of six transfections per condition. A one-way ANOVA (F3,20 = 48.479; P < 0.0001) and
subsequent post hoc Bonferroni comparison showed a significant elevation of luciferase activity by BDNF (P < 0.0001), which was
attenuated by both SB-747651A (P < 0.0001) and PD184350 (P < 0.0001). PD184350 was also more effective in attenuating BDNF-
stimulated luciferase activity than SB-747651A (P = 0.044). (E) Wild-type or MSK1 D194A KI cortical neurons were transfected with the Arc/
Arg3.1 promoter luciferase reporter construct, stimulated with 50 ngmL1 BDNF for 4 h, lysed and luciferase activity measured. Error bars
represent the standard deviation of measurements on independent cultures from three animals per genotype. A two-way ANOVA showed a
significant effect of treatment (F1,8 = 429.607; P < 0.0001) and genotype (F1,8 = 176.376; P < 0.0001), and a significant
genotype 9 treatment interaction (F1,8 = 118.487; P < 0.0001). Post hoc Bonferroni comparison showed a significant difference in BDNF-
dependent luciferase induction between wild-type and MSK1 D194A KI neurons (P < 0.0001). For A, D and E, P values of < 0.05, 001 and
0.0001 are indicated by *, ** and ***, respectively.
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it played a similar role in response to the glutamate
receptor agonist NMDA. As expected, Arc/Arg3.1
mRNA levels were induced by NMDA in wild-type
cells (Fig. 6A). Compared to what was observed with
BDNF, the MSK1 D194A KI neurons had only a rel-
atively small effect on Arc/Arg3.1 mRNA induction in
response to NMDA stimulation (Fig. 6A) indicative of
a positive role for MSK1 in the induction of Arc/
Arg3.1 following the activation of NMDA receptors.
NMDA was less effective at promoting the induction
of Arc/Arg3.1 mRNA (compare fold induction
between Figs 1A and 6A). A stronger induction of
Arc/Arg3.1 mRNA by BDNF relative to NMDA has
also been reported in rat cortical neurons [51]. Consis-
tent with the lower induction and reduced dependency
on MSK1, NMDA did not strongly induce the phos-
phorylation of histone H3 at the Arc/Arg3.1 promoter
in the region of the SRE (Fig. 6B).
Discussion
We show here that MSK1 is required for the maximal
induction of Arc/Arg3.1 mRNA in response to BDNF
in primary neuronal cultures. This was independent of
the ability of MSKs to phosphorylate CREB but cor-
related with the phosphorylation of histone H3 at the
Arc/Arg3.1 promoter. While most MSK-regulated
genes described to date are regulated by CREB phos-
phorylation [9], the ability of MSK to phosphorylate
other substrates suggests that CREB-independent
MSK-mediated gene regulation will occur. Related to
this, recent studies have proposed that MSKs may also
regulate gene induction at the level of chromatin via
phosphorylation of histone H3 [52–54]. While many of
the stimuli that induce CREB activation also stimulate
Arc/Arg3.1 expression, a clear link from CREB to the
Arc/Arg3.1 promoter has not hitherto been estab-
lished.
Arc/Arg3.1 has been found to be upregulated fol-
lowing intrahippocampal infusion of BDNF in an
ERK1/2-dependent manner. This study also showed
that CREB Ser133 phosphorylation was also ERK1/2-
dependent in this model [55]. Previous reports have
however noted the lack of a CREB binding site in the
proximal Arc/Arg3.1 promoter [56]. A CREB binding
site has, however, been identified in a synaptic activity-
responsive element 5 kb upstream of the Arc/Arg3.1
gene [57]. The binding of CREB to this element was
demonstrated by ChIP and mutation of the CREB
binding site in this element reduced its ability to
respond to increased neuronal activity in reporter
assays in cultures from the rat neocortex or hippocam-
pus [57]. In contrast, in a mouse cortical neuron
A
B
Fig. 3. Arc/Arg3.1 mRNA induction by BDNF is independent of
CREB phosphorylation. (A) Wild-type, MSK1/2 knockout or CREB
S133A KI cortical neuronal cultures were stimulated with
50 ngmL1 BDNF for 1 h and the induction of nur77 mRNA
determined by qPCR. (B) Wild-type or CREB S133A KI cortical
neuronal cultures were stimulated with 50 ngmL1 BDNF for 1 or
4 h and Arc/Arg3.1 mRNA induction determined by qPCR. Error
bars represent the standard deviation of four to six stimulations.
For A, in the MSK1 KO experiments (left panel), a two-way
ANOVA showed a significant effect of BDNF treatment
(F1,12 = 766.757; P < 0.0001) and genotype (F1,12 = 481.097;
P < 0.0001), and a significant genotype 9 treatment interaction
(F1,12 = 482.316; P < 0.0001) on BDNF-dependent induction of
Nur77. Post hoc Bonferroni comparison showed a significant
difference in BDNF-dependent luciferase induction between wild-
type and MSK1 KO neurons (P < 0.0001). In the CREB S133A KI
experiments (right panel), a two-way ANOVA showed a significant
effect of BDNF treatment (F1,13 = 21.162; P < 0.001) and genotype
(F1,12 = 15.868; P = 0.0016), and a significant
genotype 9 treatment interaction (F1,13 = 15.484; P = 0.0017) on
BDNF-dependent induction of Nur77. Post hoc Bonferroni
comparison showed a significant difference in BDNF-dependent
luciferase induction between wild-type and CREB S133A KI
neurons (P < 0.001), but no significant induction by BDNF of Nur77
in CREB S133A KI neurons. For B, a two-way ANOVA revealed a
significant effect of duration of BDNF exposure on Arc/Arg3.1
mRNA induction (F2,29 = 62.446; P < 0.0001), but no effect of
genotype (F1,29 = 0.286; P = 0.597) and no interaction between
genotype and duration of exposure (F2,29 = 0.684; P = 0.513)
indicating that the induction of Arc/Arg3.1 mRNA is independent of
the S133 residue of CREB. For A and B, P values of < 0.001 and
0.0001 are indicated by ** and ***, respectively.
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culture system, we did not observe any difference in
Arc/Arg3.1 induction in response to BDNF in neurons
expressing a Ser133Ala CREB mutation. In wild-type
cells, BDNF was able to stimulate CREB phosphory-
lation in the cortical neuronal cultures (Fig. 1D) sug-
gesting that this was not due to a failure to activate
A
B
C
Fig. 4. MSK1 promotes histone H3 phosphorylation at the Arc/Arg3.1 promoter. (A) The genomic structure of the Arc/Arg3.1 gene is shown
including the positions of the SRE and Egr binding site. The positions of the three primer sets used for ChIP analysis are indicated. (B) Wild-
type primary cortical neurons were either left unstimulated or stimulated with 50 ngmL1 of BDNF for 30 min. Following cross-linking, cells
were lysed and samples prepared for ChIP prepared as described in the Methods. After ChIP using either a phospho-Ser10 histone H3
antibody or control IgG, qPCR was used to quantify the levels of different regions of the Arc/Arg3.1 locus corresponding to the regions
amplified by the p3/p4 or p5/p6 primer sets. Signal from input DNA was used to correct for loading, and fold change calculated relative to
the unstimulated phospho Ser10 ChIP levels. (C) as (B) except primer P1 and p2 as well as cells from either wild-type or MSK1 D194A KI
neuronal cultures were used. Error bars represent the standard deviation of stimulations from three independent cultures. For the P3/P4
locus in B, a two-way ANOVA showed a significant enrichment of the ChIP signal derived from the anti p-S10 H3 antibody (F1,8 = 30.714;
P < 0.001), but a post hoc Bonferroni comparison showed no significant effect of BDNF on the anti p-S10 H3 signal (P = 0.0506). For the
P5/P6 locus, a similar analysis revealed an enrichment of the ChIP signal by the anti p-S10 H3 antibody (F1,8 = 14.730; P = 0.005), but no
significant effect of BDNF on the anti p-S10 H3 signal (P = 0.584). For the analysis of P1/P2 ChIP signals derived from the use of the anti p-
S10 H3 antibody in C, a two-way ANOVA showed a significant effect of BDNF treatment (F1,7 = 17.778; P = 0.004), which a post hoc
Bonferroni comparison showed was specific to wild-type neurons (P = 0.012) since no significant stimulation was observed in neurons from
MSK1 D194A KI mice (P = 1). For C, a P value of < 0.05 is indicated by *.
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CREB. Consistent with this induction of mRNA for
nur77, a known CREB target was reduced in the
CREB S133A KI neurons. The difference between our
findings and those in [57] could be explained by several
factors. Synaptic activity and BDNF may utilise differ-
ent transcription factors and promoter elements to
control Arc/Arg3.1 expression [58]. Alternatively, the
activity of CREB at the synaptic activity-responsive
element in the Arc/Arg3.1 promoter may be indepen-
dent of Ser133 phosphorylation. For example, CRTC
coactivator proteins can bind to CREB independently
of Ser133 phosphorylation [59,60]. Furthermore, it was
recently shown that CRTC3 recruitment can promote
CREB-dependent transcription in cells from CREB
Ser133Ala KI mice demonstrating that in some cir-
cumstances CREB function can be Ser133-independent
[11].
The synaptic activity-responsive element also con-
tained binding sites for the serum response complex
and MEF2, and this MEF2–CREB–SRE motif has
subsequently been identified in other activity-regulated
genes [61]. The identification of SREs in Arc/Arg3.1
promoter has been reported previously [57,62]. These
studies, which were also performed in primary neu-
ronal cultures, have shown that in addition to the
proximal SRE shown in Fig. 4, at least two more dis-
tal SREs exist in the Arc/Arg3.1 promoter [57,62]. In
particular, a distal SRE 6.5 kb upstream of Arc/
Arg3.1 has been identified as being important to the
maximal induction of Arc/Arg3.1 by BDNF [62].
Knockout of the serum response factor has also been
found to reduce Arc/Arg3.1 induction following
mGlu5 stimulation of striatal neurons or in the dentate
gyrus following electroconvulsive shock [48,49]. In the
A
B
C
Fig. 5. The Arc/Arg3.1 promoter is regulated by a SRE. (A) A
1302 to +98 fragment of the mouse Arc/Arg3.1 promoter was
cloned into a luciferase reporter. Analysis of this sequence
revealed the presence of a SRE and binding site for Egr
transcription factors. Mutated versions of the reporter construct
were created for each of these sites as described in the methods.
(B) These constructs were transfected into wild-type cortical
neuronal cultures, which were either left untreated or stimulated
for 4 h with 50 ngmL1 BDNF as indicated. Unpaired t-tests
revealed significant increases in luciferase activity in wild-type and
Egr mutant constructs compared to their corresponding
unstimulated controls (P = 0.011 and P < 0.001, respectively), but
no stimulation in the SRE mutant construct (P = 0.413). (C) MSK1
D194A KI cortical neuronal cultures were pretreated with 2 lM
PD184352 for 30 min as indicated and were stimulated with
50 ngmL1 BDNF for the indicated times and Arc/Arg3.1 mRNA
levels determined by qPCR. A one-way ANOVA showed an overall
significant difference across groups (F4,13 = 29.995; P < 0.0001)
and post hoc Bonferroni comparison confirmed the effects of the
MEK inhibitor as being highly significant at the 3 h time point
(P < 0.0001). Error bars represent the standard deviation of
between two and six independent stimulations. For B and C, P
values of < 0.05, 0.001 and 0.0001 are indicated by *, ** and ***,
respectively.
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present study, we find that the proximal SRE in the
Arc/Arg3.1 promoter can drive the expression of a
luciferase reporter. Furthermore, we find that histone
H3 phosphorylation is induced by BDNF in this
region via the ERK1/2 activated kinase MSK1, and
that this, as opposed to the phosphorylation of CREB
S133, is associated with the induction of Arc/Arg3.1.
Of note, while the proximal promoter is sufficient to
allow induction of the Arc/Arg3.1 mRNA, our results
do not exclude the possibility that the distal SRE sites
are involved and may also be regulated in an MSK-
dependent manner.
The role of histone H3 phosphorylation in the direct
regulation of Arc/Arg3.1 expression has not been
extensively studied. However, changes in chromatin
structure [63] or histone post-translational modifica-
tions in cells have been found to correlate with
changes in Arc/Arg3.1 expression in response to a
variety of in vitro and in vivo stimuli e.g. [25,26,64].
Perhaps the most direct are observations that a com-
plex comprising the histone demethylase PHF8 and
the acetyltransferase TIP60 regulate the activity-
dependent induction of Arc/Arg3.1 in a manner that is
correlated with the acetylation of lysine 9 and phos-
phorylation of serine 10 on histone H3 (H3K9acS10P)
[65]; knockdown of PHF8 resulted in both a reduction
in Arc/Arg3.1 expression and H3K9acS10P. However,
no mechanism was provided for the phosphorylation
of H3 Ser10, leaving open the possibility that MSK1
may be involved, especially since histone H3 acetyla-
tion and phosphorylation occur in vivo in an MSK1-
dependent manner [20,21].
The phosphorylation of histone H3 by MSK1 would
require the targeting of MSK1 to chromatin, but the
mechanism by which this occurs is not fully under-
stood. Our data could agree with a model in which the
SRE may be recruiting MSK1 to this region of chro-
matin. A similar mechanism has been proposed to
occur in HeLa cells at SREs in the c-fos and egr1 pro-
moters where knockdown of the ternary complex fac-
tor Elk1 reduced MSK1 recruitment to these
promoters [66]. Further studies would be required to
determine in this mechanism operated at either the
proximal or distal SREs in the Arc/Arg3.1 promoter.
In particular, while our studies indicate that MSKs
may be able to regulate the proximal region in the
Arc/Arg3.1 promoter, they do not exclude that MSKs
may also play a role at the distal control elements.
Equally, it will be important to establish the general
nature of these observations beyond primary neuronal
cultures and in the developmentally mature central
nervous system.
In conclusion, our observations are consistent with a
prominent role of MSK1 in BDNF-dependent regula-
tion of Arc/Arg3.1, an IE gene critical for a range of
synaptic and experience-dependent synaptic plasticity
[35]. Moreover, our findings of the importance of his-
tone H3 phosphorylation in Arc/Arg3.1 induction pro-
vide a novel mechanism of Arc/Arg3.1 regulation
A
B
Fig. 6. MSK1 activity is not critical to the induction of Arc/Arg3.1
mRNA by NMDA. (A) Wild-type or MSK1 D194A KI neuronal
cultures were stimulated for the indicated times with 20 lM
NMDA. Cells were the lysed and Arc/Arg3.1 mRNA induction
measured by qPCR. Error bars represent the standard deviation
from eight stimulations per genotype. A two-way ANOVA showed
a significant main effect of genotype (F1,69 = 12.383, P < 0.001) on
Arc/Arg3.1 induction by NMDA in wild-type and MSK1 D194A KI
neurons, which a Bonferroni post hoc comparison showed was
significant at the 1 h time point (P < 0.0001). (B) Wild-type or
MSK1 D194A KI neuronal cultures were stimulated for 30 min with
20 lM NMDA. After cross-linking, cells were lysed and samples
prepared for ChIP prepared as described in the Methods. ChIP was
carried out using either a phospho-Ser10 histone H3 antibody or
control IgG. qPCR was then used to quantify the change in histone
phosphorylation at the Arc/Arg3.1 locus using the p1/p2 primer set
shown in Figure 4A. For the analysis of ChIP signals derived from
the use of the anti p-S10 H3 antibody, a two-way ANOVA showed
no significant effects of NMDA treatment (F1,7 = 3.616; P = 0.099),
nor of genotype (F1,7 = 0.063; P = 0.809) nor an interaction
between the two (F1,7 = 0.063; P = 0.809). For A, a P value of
< 0.0001 is indicated by ***.
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involving epigenetic modifications of the genome and
chromatin remodelling. Such modifications are increas-
ingly becoming appreciated as prime regulators of
synaptic and cognitive function and as therapeutic tar-
gets for a range of neurological disorders [67,68].
Given the ability of MSK1 to regulate Arc/Arg3.1
induction, MSK1 represents a plausible target for drug
discovery programs aimed at improving cognition.
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